​

Medtronic (MDT) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

MDT Stock Forecast

Medtronic (MDT) stock forecast, based on 49 Wall Street analysts, predicts a 12-month average price target of $109.50, with a high of $120.00 and a low of $95.00. This represents a 42.54% increase from the last price of $76.82.

$75 $84 $93 $102 $111 $120 High: $120 Avg: $109.5 Low: $95 Last Closed Price: $76.82

MDT Stock Rating

Medtronic stock's rating consensus is Buy, based on 49 Wall Street analysts. The breakdown includes 1 Strong Buy (2.04%), 26 Buy (53.06%), 22 Hold (44.90%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 49 22 26 1 Strong Sell Sell Hold Buy Strong Buy

MDT Price Target Upside V Benchmarks

TypeNameUpside
StockMedtronic42.54%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks38.85%

Price Target Trends

1M3M12M
# Anlaysts2824
Avg Price Target$95.00$109.13$110.00
Last Closing Price$76.82$76.82$76.82
Upside/Downside23.67%42.06%43.19%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
May, 2641411--29
Apr, 2641412--30
Mar, 2651412--31
Feb, 2631314--30
Jan, 2641215--31
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Apr 23, 2026Matthew TaylorJefferies$95.00$83.7913.38%23.67%
Apr 15, 2026Richard NewitterTruist Financial$95.00$86.889.35%23.67%
Apr 13, 2026Mizuho Securities$120.00$86.7538.33%56.21%
Apr 09, 2026Vijay KumarEvercore ISI$106.00$87.9120.58%37.98%
Mar 10, 2026Mike KratkyLeerink Partners$119.00$90.3131.77%54.91%
Mar 10, 2026Michael MatsonNeedham$120.00$90.2133.02%56.21%
Feb 18, 2026Robert W. Baird$100.00$96.413.72%30.17%
Feb 18, 2026Matt MiksicBarclays$118.00$96.4122.39%53.61%
Feb 09, 2026Needham$121.00$102.9017.59%57.51%
Feb 04, 2026UBS$104.00$103.380.60%35.38%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Apr 23, 2026JefferiesHoldHoldhold
Apr 09, 2026Evercore ISIOutperformOutperformhold
Mar 10, 2026Leerink PartnersOutperformOutperformhold
Mar 10, 2026NeedhamBuyBuyhold
Feb 18, 2026BarclaysOverweightOverweighthold
Feb 09, 2026NeedhamHoldBuyupgrade
Feb 04, 2026UBSNeutralNeutralhold
Feb 03, 2026Leerink PartnersOutperformOutperformhold
Jan 30, 2026CICCOutperforminitialise
Jan 09, 2026BernsteinOutperformOutperformhold

Financial Forecast

EPS Forecast

$2 $3 $4 $5 $6 $7 $8 Apr 22 Apr 23 Apr 24 Apr 25 Apr 26 Apr 27 Apr 28 Apr 29
Apr 22Apr 23Apr 24Apr 25Apr 26Apr 27Apr 28Apr 29
Reported$3.75$2.83$2.77$3.63----
Avg Forecast$5.66$5.27$5.20$5.45$5.84$6.30$6.85$7.36
High Forecast$5.72$5.33$5.23$5.47$5.88$6.65$6.92$7.44
Low Forecast$5.60$5.22$5.19$5.44$5.76$4.95$6.78$7.29
Surprise %-33.75%-46.30%-46.73%-33.39%----

Revenue Forecast

$30B $33B $36B $39B $42B $45B Apr 22 Apr 23 Apr 24 Apr 25 Apr 26 Apr 27 Apr 28 Apr 29
Apr 22Apr 23Apr 24Apr 25Apr 26Apr 27Apr 28Apr 29
Reported$31.69B$31.23B$32.36B$33.54B----
Avg Forecast$32.02B$30.94B$32.22B$33.57B$35.14B$36.89B$39.10B$41.02B
High Forecast$32.28B$31.25B$32.26B$33.65B$35.36B$36.91B$39.42B$41.35B
Low Forecast$31.76B$30.63B$32.16B$33.47B$34.94B$36.88B$38.79B$40.70B
Surprise %-1.05%0.94%0.44%-0.11%----

Net Income Forecast

$3B $4B $6B $7B $9B $10B Apr 22 Apr 23 Apr 24 Apr 25 Apr 26 Apr 27 Apr 28 Apr 29
Apr 22Apr 23Apr 24Apr 25Apr 26Apr 27Apr 28Apr 29
Reported$5.04B$3.76B$3.68B$4.66B----
Avg Forecast$4.39B$7.02B$4.29B$7.26B$7.74B$7.72B$9.11B$9.79B
High Forecast$5.27B$7.09B$5.15B$7.28B$7.82B$8.85B$9.21B$9.90B
Low Forecast$3.51B$6.94B$3.43B$7.24B$7.66B$6.58B$9.02B$9.70B
Surprise %14.78%-46.43%-14.27%-35.77%----

MDT Forecast FAQ

Is Medtronic stock a buy?

Medtronic stock has a consensus rating of Buy, based on 49 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 26 Buy, 22 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Medtronic is a favorable investment for most analysts.

What is Medtronic's price target?

Medtronic's price target, set by 49 Wall Street analysts, averages $109.5 over the next 12 months. The price target range spans from $95 at the low end to $120 at the high end, suggesting a potential 42.54% change from the previous closing price of $76.82.

How does Medtronic stock forecast compare to its benchmarks?

Medtronic's stock forecast shows a 42.54% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical device stocks industry (38.85%).

What is the breakdown of analyst ratings for Medtronic over the past three months?

  • May 2026: 13.79% Strong Buy, 48.28% Buy, 37.93% Hold, 0% Sell, 0% Strong Sell.
  • April 2026: 13.33% Strong Buy, 46.67% Buy, 40.00% Hold, 0% Sell, 0% Strong Sell.
  • March 2026: 16.13% Strong Buy, 45.16% Buy, 38.71% Hold, 0% Sell, 0% Strong Sell.

What is Medtronic’s EPS forecast?

Medtronic's average annual EPS forecast for its fiscal year ending in April 2026 is $5.84, marking a 60.88% increase from the reported $3.63 in 2025. Estimates for the following years are $6.3 in 2027, $6.85 in 2028, and $7.36 in 2029.

What is Medtronic’s revenue forecast?

Medtronic's average annual revenue forecast for its fiscal year ending in April 2026 is $35.14B, reflecting a 4.79% increase from the reported $33.54B in 2025. The forecast for 2027 is $36.89B, followed by $39.1B for 2028, and $41.02B for 2029.

What is Medtronic’s net income forecast?

Medtronic's net income forecast for the fiscal year ending in April 2026 stands at $7.74B, representing an 66.11% increase from the reported $4.66B in 2025. Projections indicate $7.72B in 2027, $9.11B in 2028, and $9.79B in 2029.